Bottlenecks in the production of antiviral drug remdesivir have led to policymakers threatening compulsory licensing and economic sanctions. It’s a foretaste of what may come when a coronavirus vaccine becomes available.
Is compulsory licensing of remdesivir a feasible option?
Leave a reply
Foreaders 